Identification of suitable controls for miRNA quantification in T-cells and whole blood cells in sepsis.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
31 10 2019
Historique:
received: 04 06 2019
accepted: 20 09 2019
entrez: 2 11 2019
pubmed: 2 11 2019
medline: 4 11 2020
Statut: epublish

Résumé

Complex immune dysregulation is a hallmark of sepsis. The occurring phases of immunosuppression and hyperinflammation require rapid detection and close monitoring. Reliable tools to monitor patient's immune status are yet missing. Currently, microRNAs are being discussed as promising new biomarkers in sepsis. However, no suitable internal control for normalization of miRNA expression by qPCR has been validated so far, thus hampering their potential benefit. We here present the first evaluation of endogenous controls for miRNA analysis in human sepsis. Novel candidate reference miRNAs were identified via miRNA microArray. TaqMan qPCR assays were performed to evaluate these microRNAs in T-cells and whole blood cells of sepsis patients and healthy controls in two independent cohorts. In T-cells, U48 and miR-320 proved suitable as endogenous controls, while in whole blood cells, U44 and miR-942 provided best stability values for normalization of miRNA quantification. Commonly used snRNA U6 exhibited worst stability in all sample groups. The identified internal controls have been prospectively validated in independent cohorts. The critical importance of housekeeping gene selection is emphasized by exemplary quantification of imuno-miR-150 in sepsis patients. Use of appropriate internal controls could facilitate research on miRNA-based biomarker-use and might even improve treatment strategies in the future.

Identifiants

pubmed: 31672997
doi: 10.1038/s41598-019-51782-w
pii: 10.1038/s41598-019-51782-w
pmc: PMC6823537
doi:

Substances chimiques

Biomarkers 0
MIRN320 microRNA, human 0
MIRN942 microRNA, human 0
MicroRNAs 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

15735

Références

JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Biochem Biophys Res Commun. 2014 Nov 7;454(1):210-4
pubmed: 25450382
Shock. 2013 Nov;40(5):358-65
pubmed: 24088989
Int J Mol Med. 2015 Nov;36(5):1400-8
pubmed: 26352225
Crit Care. 2013 Apr 27;17(2):R81
pubmed: 23622086
Mol Med. 2018 Oct 17;24(1):54
pubmed: 30332984
Dig Dis Sci. 2012 Apr;57(4):897-904
pubmed: 22198701
JAMA. 2011 Dec 21;306(23):2594-605
pubmed: 22187279
BMC Mol Biol. 2010 Jan 20;11:8
pubmed: 20089196
Eur J Cardiothorac Surg. 2002 Feb;21(2):232-44
pubmed: 11825729
Crit Care. 2015 Dec 18;19:440
pubmed: 26683209
Curr Genomics. 2010 Nov;11(7):537-61
pubmed: 21532838
Cancer Lett. 2018 Sep 1;431:11-21
pubmed: 29800684
Crit Care Med. 2019 Aug;47(8):e700-e709
pubmed: 31149961
Nat Rev Mol Cell Biol. 2007 Mar;8(3):209-20
pubmed: 17318225
Cancer Res. 2004 Aug 1;64(15):5245-50
pubmed: 15289330
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
Nat Rev Immunol. 2013 Dec;13(12):862-74
pubmed: 24232462
Genome Biol. 2002 Jun 18;3(7):RESEARCH0034
pubmed: 12184808
Clin Chem. 2015 Nov;61(11):1333-42
pubmed: 26408530
Breast Cancer Res Treat. 2014 Aug;147(1):61-8
pubmed: 25086636
Cytokine. 2015 Jan;71(1):89-100
pubmed: 25265569
Anesth Analg. 2018 Feb;126(2):670-681
pubmed: 28922229
Ann Thorac Surg. 1996 Jun;61(6):1607-8
pubmed: 8651756
Virulence. 2014 Jan 1;5(1):45-56
pubmed: 24067565
Exp Mol Med. 2013 Sep 20;45:e42
pubmed: 24052167
Nature. 2010 Aug 12;466(7308):835-40
pubmed: 20703300
PLoS One. 2015 May 26;10(5):e0127443
pubmed: 26010841
J Exp Bot. 2004 Jul;55(402):1445-54
pubmed: 15208338
Cardiol J. 2016;23(6):694-703
pubmed: 27976798
Int J Mol Sci. 2016 Jan 09;17(1):
pubmed: 26761003
BMC Dev Biol. 2015 Jun 12;15:25
pubmed: 26062615
RNA Biol. 2012 Jun;9(6):850-9
pubmed: 22699556
PLoS One. 2013;8(1):e54612
pubmed: 23372743
Sci Rep. 2018 Jan 25;8(1):1568
pubmed: 29371606
Crit Care. 2010;14(1):R15
pubmed: 20144219
Cell Death Differ. 2015 Jan;22(1):22-33
pubmed: 25190144
Trends Mol Med. 2014 Aug;20(8):460-9
pubmed: 25027972
Eur J Immunol. 2015 Jan;45(1):260-72
pubmed: 25308712
Nat Protoc. 2008;3(6):1101-8
pubmed: 18546601
J Appl Genet. 2013 Nov;54(4):391-406
pubmed: 24078518
Bioinformatics. 2007 Oct 15;23(20):2700-7
pubmed: 17720982
Crit Care Med. 2013 Feb;41(2):580-637
pubmed: 23353941
Virulence. 2014 Jan 1;5(1):4-11
pubmed: 24335434
Genes Immun. 2005 Jun;6(4):279-84
pubmed: 15815687
Biotechnol Lett. 2004 Mar;26(6):509-15
pubmed: 15127793
Shock. 2007 May;27(5):466-73
pubmed: 17438450
Breast Cancer Res. 2010;12(6):R90
pubmed: 21047409
Biochimie. 2011 Nov;93(11):1987-92
pubmed: 21664409
BMC Genomics. 2014 Jun 14;15:474
pubmed: 24928098
BMC Res Notes. 2011 Oct 20;4:427
pubmed: 22011438
BMC Res Notes. 2014 Oct 10;7:715
pubmed: 25304816
J Exp Med. 2011 Dec 19;208(13):2581-90
pubmed: 22110166
J Biotechnol. 1999 Oct 8;75(2-3):291-5
pubmed: 10617337
J Immunol. 2018 Mar 1;200(5):1543-1553
pubmed: 29463691
BMC Cancer. 2015 Oct 24;15:774
pubmed: 26499892
Anesthesiology. 2016 Apr;124(4):908-22
pubmed: 26978146
RNA. 2008 May;14(5):844-52
pubmed: 18375788
PLoS One. 2015 Aug 11;10(8):e0135527
pubmed: 26263001
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
Clin Microbiol Infect. 2017 Feb;23(2):104-109
pubmed: 27856268

Auteurs

Simon Hirschberger (S)

Department of Anaesthesiology and Intensive Care Medicine, University Hospital, Ludwig Maximilian University (LMU), Munich, Germany.
Walter-Brendel-Center of Experimental Medicine, Ludwig Maximilian University (LMU), Munich, Germany.

Max Hübner (M)

Department of Anaesthesiology and Intensive Care Medicine, University Hospital, Ludwig Maximilian University (LMU), Munich, Germany.
Walter-Brendel-Center of Experimental Medicine, Ludwig Maximilian University (LMU), Munich, Germany.

Gabriele Strauß (G)

Department of Anaesthesiology and Intensive Care Medicine, University Hospital, Ludwig Maximilian University (LMU), Munich, Germany.
Walter-Brendel-Center of Experimental Medicine, Ludwig Maximilian University (LMU), Munich, Germany.

David Effinger (D)

Department of Anaesthesiology and Intensive Care Medicine, University Hospital, Ludwig Maximilian University (LMU), Munich, Germany.
Walter-Brendel-Center of Experimental Medicine, Ludwig Maximilian University (LMU), Munich, Germany.

Michael Bauer (M)

Department of Anaesthesiology and Intensive Care Medicine, Friedrich-Schiller University, Jena, Germany.
Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany.

Sebastian Weis (S)

Department of Anaesthesiology and Intensive Care Medicine, Friedrich-Schiller University, Jena, Germany.
Center for Sepsis Control and Care, Jena University Hospital, Jena, Germany.
Institute for Infectious Disease and Infection Control, Jena University Hospital, Jena, Germany.

Evangelos J Giamarellos-Bourboulis (EJ)

4th Department of Internal Medicine, ATTIKON University Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Simone Kreth (S)

Department of Anaesthesiology and Intensive Care Medicine, University Hospital, Ludwig Maximilian University (LMU), Munich, Germany. simone.kreth@med.uni-muenchen.de.
Walter-Brendel-Center of Experimental Medicine, Ludwig Maximilian University (LMU), Munich, Germany. simone.kreth@med.uni-muenchen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH